162 related articles for article (PubMed ID: 37948573)
21. [Clinical and morphological features of different types of Castleman's disease].
Melikyan AL; Egorova EK; Kovrigina АМ; Subortseva IN; Gilyazitdinova EA; Karagyulyan SR; Silaev MA; Gemdzhian EG; Savchenko VG
Ter Arkh; 2015; 87(7):64-71. PubMed ID: 26390727
[TBL] [Abstract][Full Text] [Related]
22. Molecular analysis of clonality in Castleman's disease.
Soulier J; Grollet L; Oksenhendler E; Micléa JM; Cacoub P; Baruchel A; Brice P; Clauvel JP; d'Agay MF; Raphael M
Blood; 1995 Aug; 86(3):1131-8. PubMed ID: 7620166
[TBL] [Abstract][Full Text] [Related]
23. Presentation and Outcome of Castleman's Disease in Immunocompetent Hosts.
Prakash G; Bal A; Malhotra P; Aggarwal V; Khadwal A; Suri V; Jain S; Kumari S; Srinivasan R; Das A; Varma N; Varma S
Indian J Hematol Blood Transfus; 2016 Dec; 32(4):468-474. PubMed ID: 27812258
[TBL] [Abstract][Full Text] [Related]
24. Concurrence of localized Castleman's disease and peripheral small B-Lymphocytic lymphoma within the same lymph node.
Orcioni GF; Mambelli V; Ascani S; Sabattini E; Piccioli M; Pieri F; Falini B; Pileri SA
Gen Diagn Pathol; 1998 Apr; 143(5-6):327-30. PubMed ID: 9653916
[TBL] [Abstract][Full Text] [Related]
25. Multicentric Castleman's disease in India - Does EBV rather than HHV8 play a role?
Bhanvadia V; Shet T; Rao V; Epari S; Gujral S; Jain H; Bagal B; Sengar M
Indian J Pathol Microbiol; 2021; 64(2):302-309. PubMed ID: 33851624
[TBL] [Abstract][Full Text] [Related]
26. A clinical case of Castleman's disease.
Macedo JE; Abreu I; Marques M; Henrique R; Araújo A
J Thorac Oncol; 2007 Mar; 2(3):259-60. PubMed ID: 17410052
[TBL] [Abstract][Full Text] [Related]
27. Human Herpes Virus-8-Associated Multicentric Castleman's Disease in a Human Immunodeficiency Virus-Positive Patient with a Previous History of Kaposi's Sarcoma.
Huang G; Low G
J Clin Imaging Sci; 2015; 5():59. PubMed ID: 26664776
[TBL] [Abstract][Full Text] [Related]
28. Treatment of multicentric Castleman's disease complicated by the development of non-Hodgkin's lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support.
Advani R; Warnke R; Rosenberg S
Ann Oncol; 1999 Oct; 10(10):1207-9. PubMed ID: 10586338
[TBL] [Abstract][Full Text] [Related]
29. A unicentric center, multicenter, and mixed-type Castleman disease: Three case reports and a review of the literature.
Xu Y; Shao S; Kang H; Xu Z; Wen G; Shan Y; Gong Z; Al-Sharabi A; Qu B; Ren Y; Zhang F; Guan J; Chen X
Medicine (Baltimore); 2024 Apr; 103(15):e37722. PubMed ID: 38608101
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of 225 Castleman's diseases in the oral maxillofacial and neck region: a rare disease revisited.
He X; Wang Q; Wu Y; Hu J; Wang D; Qi B; Zhang W; Wang Y; Cheng J
Clin Oral Investig; 2018 Apr; 22(3):1285-1295. PubMed ID: 28980074
[TBL] [Abstract][Full Text] [Related]
31. Plasma cell variant of Castleman's disease occurring concurrently with Hodgkin's disease in the neck.
Frank DK; Charney D; Kashani A
Head Neck; 2001 Feb; 23(2):166-9. PubMed ID: 11303634
[TBL] [Abstract][Full Text] [Related]
32. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
Parravicini C; Corbellino M; Paulli M; Magrini U; Lazzarino M; Moore PS; Chang Y
Am J Pathol; 1997 Dec; 151(6):1517-22. PubMed ID: 9403701
[TBL] [Abstract][Full Text] [Related]
33. Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases.
Lajoie G; Kumar S; Min KW; Silva FG
Am J Surg Pathol; 1995 Sep; 19(9):1021-8. PubMed ID: 7661275
[TBL] [Abstract][Full Text] [Related]
34. [Transitional type of Castleman's disease manifested as the POEMS syndrome].
Tomić I; Plavec G; Tasić O; Ristanović A; Cvijanović V
Vojnosanit Pregl; 2004; 61(4):439-44. PubMed ID: 15552541
[TBL] [Abstract][Full Text] [Related]
35. [Diagnosis and treatment of 41 cases of head and neck Castleman's disease].
Xue JF; Hao Q; Zhang YM; Cao PD; Song SP; Hu RF; Jin S
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Aug; 53(8):610-614. PubMed ID: 30122000
[No Abstract] [Full Text] [Related]
36. [Diagnosis and surgical treatment of Castleman's disease].
Ma SH; Liu QJ; Zhang YC; Yang R
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1118-21. PubMed ID: 21609596
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological Profile of Castleman's Disease in Indian Population: Experience From a Tertiary Care Center.
Singh A; Purkait S; Mallick S; Ramteke P; Das CK; Gogia A; Sharma MC; Kumar L
Indian J Hematol Blood Transfus; 2020 Apr; 36(2):254-259. PubMed ID: 32425374
[TBL] [Abstract][Full Text] [Related]
38. Current diagnosis and treatment of Castleman's disease.
González García A; Moreno Cobo MÁ; Patier de la Peña JL
Rev Clin Esp (Barc); 2016 Apr; 216(3):146-56. PubMed ID: 26749192
[TBL] [Abstract][Full Text] [Related]
39. Rituximab as a First-line Treatment for Autoimmune Hemolytic Anemia in Multicentric Castleman's Disease.
Cáceres Medina JL; González Torres LA; Gamboa-Meza A; Cantu-Rodriguez OG
Cureus; 2024 Apr; 16(4):e59080. PubMed ID: 38800203
[TBL] [Abstract][Full Text] [Related]
40. Multicentric Castleman's disease, non-Hodgkin's lymphoma, and Kaposi's sarcoma: a rare simultaneous occurrence.
Sukpanichnant S; Sivayathorn A; Visudhiphan S; Ngowthammatas W
Asian Pac J Allergy Immunol; 2002 Jun; 20(2):127-33. PubMed ID: 12403198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
